27 August 2026
Peptides aimed at lesion survival, not hormones
Xtalks, 27 August 2026: Endocyclic CEO Tanya Petrossian says ENDO-205-class peptides starve lesions into apoptosis without cycling hormones.
The full briefing is in the app.
27 August 2026
Xtalks, 27 August 2026: Endocyclic CEO Tanya Petrossian says ENDO-205-class peptides starve lesions into apoptosis without cycling hormones.
The full briefing is in the app.